KR20070091482A - Cosmetic composition for protecting sebum secretion on the skin - Google Patents

Cosmetic composition for protecting sebum secretion on the skin Download PDF

Info

Publication number
KR20070091482A
KR20070091482A KR1020060021063A KR20060021063A KR20070091482A KR 20070091482 A KR20070091482 A KR 20070091482A KR 1020060021063 A KR1020060021063 A KR 1020060021063A KR 20060021063 A KR20060021063 A KR 20060021063A KR 20070091482 A KR20070091482 A KR 20070091482A
Authority
KR
South Korea
Prior art keywords
extract
cosmetic composition
sebum
ivy
hawthorn
Prior art date
Application number
KR1020060021063A
Other languages
Korean (ko)
Other versions
KR101252550B1 (en
Inventor
조준철
이준배
남개원
한상훈
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Priority to KR1020060021063A priority Critical patent/KR101252550B1/en
Publication of KR20070091482A publication Critical patent/KR20070091482A/en
Application granted granted Critical
Publication of KR101252550B1 publication Critical patent/KR101252550B1/en

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B62LAND VEHICLES FOR TRAVELLING OTHERWISE THAN ON RAILS
    • B62MRIDER PROPULSION OF WHEELED VEHICLES OR SLEDGES; POWERED PROPULSION OF SLEDGES OR SINGLE-TRACK CYCLES; TRANSMISSIONS SPECIALLY ADAPTED FOR SUCH VEHICLES
    • B62M11/00Transmissions characterised by the use of interengaging toothed wheels or frictionally-engaging wheels
    • B62M11/04Transmissions characterised by the use of interengaging toothed wheels or frictionally-engaging wheels of changeable ratio
    • B62M11/14Transmissions characterised by the use of interengaging toothed wheels or frictionally-engaging wheels of changeable ratio with planetary gears
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B62LAND VEHICLES FOR TRAVELLING OTHERWISE THAN ON RAILS
    • B62MRIDER PROPULSION OF WHEELED VEHICLES OR SLEDGES; POWERED PROPULSION OF SLEDGES OR SINGLE-TRACK CYCLES; TRANSMISSIONS SPECIALLY ADAPTED FOR SUCH VEHICLES
    • B62M11/00Transmissions characterised by the use of interengaging toothed wheels or frictionally-engaging wheels
    • B62M11/04Transmissions characterised by the use of interengaging toothed wheels or frictionally-engaging wheels of changeable ratio
    • B62M11/14Transmissions characterised by the use of interengaging toothed wheels or frictionally-engaging wheels of changeable ratio with planetary gears
    • B62M11/16Transmissions characterised by the use of interengaging toothed wheels or frictionally-engaging wheels of changeable ratio with planetary gears built in, or adjacent to, the ground-wheel hub
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16HGEARING
    • F16H1/00Toothed gearings for conveying rotary motion
    • F16H1/28Toothed gearings for conveying rotary motion with gears having orbital motion
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16HGEARING
    • F16H3/00Toothed gearings for conveying rotary motion with variable gear ratio or for reversing rotary motion
    • F16H3/003Toothed gearings for conveying rotary motion with variable gear ratio or for reversing rotary motion the gear-ratio being changed by inversion of torque direction
    • F16H3/005Toothed gearings for conveying rotary motion with variable gear ratio or for reversing rotary motion the gear-ratio being changed by inversion of torque direction for gearings using gears having orbital motion
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16HGEARING
    • F16H3/00Toothed gearings for conveying rotary motion with variable gear ratio or for reversing rotary motion
    • F16H3/44Toothed gearings for conveying rotary motion with variable gear ratio or for reversing rotary motion using gears having orbital motion

Landscapes

  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Combustion & Propulsion (AREA)
  • Transportation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A sebum secretion inhibiting cosmetic composition is provided to be effective for inhibiting the sebum excessively secreted from skin by inhibiting the activity of 5alpha-reductase which is an enzyme for catalyzing the formation of dehydrotestosterone known to be inducing the sebum secretion. A cosmetic composition for inhibiting sebum secretion comprises an extract of Crataegus pinnatifida(hawthorn), an extract of Parthenocissus tricuspidata(Ivy) and an extract of Syzygium aromaticum(clove), where the total content of extracts regarding the weight of the composition is 0.001-10 wt.%.

Description

피지분비 억제용 화장료 조성물 {Cosmetic composition for protecting sebum secretion on the skin}Cosmetic composition for inhibiting sebum secretion {Cosmetic composition for protecting sebum secretion on the skin}

도 1은 본 발명의 5α-리덕테이즈 활성 저해 실험결과를 나타내는 그래프이다. 1 is a graph showing the results of 5α-reductase activity inhibition experiment of the present invention.

도 2는 본 발명의 피지분비 억제 실험결과를 나타내는 그래프이다. 2 is a graph showing the results of sebum secretion inhibition experiment of the present invention.

본 발명은 산사나무(Hawthorn) 추출물, 담쟁이덩굴(Ivy) 추출물 및 클로브(Clove) 추출물을 함유하는 피지 억제용 화장료 조성물에 관한 것이다. 상기 피지 억제용 화장료 조성물의 천연 추출물들은 피지분비를 유발한다고 알려진 디하이드로테스토스테론의 생성을 촉매하는 효소인 5α-리덕테이즈의 활성을 억제함으로써, 피부에서 과잉으로 분비되는 피지를 억제하는데 유용한 효과를 나타낸다.The present invention relates to a cosmetic composition for inhibiting sebum containing Hawthorn (Hawthorn) extract, Ivy (Ivy) extract and Clove (Clove) extract. The natural extracts of the sebum inhibiting cosmetic composition inhibit the activity of 5α-reductase, an enzyme that catalyzes the production of dihydrotestosterone, which is known to induce sebum secretion, and thus has a useful effect in inhibiting sebum secreted excessively in the skin. Indicates.

일반적으로 두피 및 얼굴을 포함한 피부에서 피지는 피부의 보습유지나 미생물의 침입을 막는 역할을 맡고 있지만, 사춘기 이후에는 여드름을 촉진시키게 된다. 특히, 30대 이후의 여성의 경우는 피지의 과잉분비로 인하여 피부의 번들거림과 화장의 들뜸, 그리고 모공확대와 같은 문제를 유발하기도 한다. 이러한 피지의 과잉분비에 대한 원인은 다양하지만, 그 가운데에 피지선의 활성에 있어 피지 분비를 촉진하는데 관여하는 호르몬 가운데 하나인 디하이드로테스토스테론의 양에 의해서 피지선의 세포가 활성화되어 피지 과분비가 일어난다고 알려져있다. In general, sebum in the skin including the scalp and face is responsible for maintaining the skin's moisturizing or microorganism invasion, but after puberty will promote acne. In particular, women in their 30s and older may cause problems such as skin swelling, makeup lifting, and pore enlargement due to excessive secretion of sebum. There are various causes for the excessive secretion of sebum, but it is known that the sebaceous gland secretion is caused by the activation of the cells of sebaceous gland by the amount of dihydrotestosterone, one of the hormones involved in promoting sebum secretion in the activity of sebaceous gland have.

5α-리덕테이즈(5α-Reductase)는 피지선, 모낭, 전립선 및 부고환 등의 남성 호르몬 반응성 조직에서 존재하며, 남성 호르몬들 중의 하나인 테스토스테론(Testosterone)을 디하이드로테스토스테론(Dihydrotestosteron:DHT)으로 환원시키는데 관여하는 효소로서 그 전환에는 니코틴아미드아데닌디뉴클레오티드인산(NADPH)을 필요로 한다. 골격근 증가와 정자 형성 등에는 테스토스테론이 관여하고, 여드름, 피지 증가 및 전립선 비대증 등에는 디하이드로테스토스테론이 해당 조직에서 관여한다고 알려졌다(Diane et al; J. Invest Dermatol. 775-778, 1995. Bruchovsky, N et al; J.B.C. 243,2112-2121, 1968). 또한, 피부의 피지선에서는 테스토스테론이 5α-리덕테이즈에 의해서 디하이드로테스토스테론으로 전환되어 세포질 내에 있는 수용체 단백질(Receptor)과 결합하여 핵내로 들어가 피지선 세포를 활성화하여 분화가 촉진됨으로써 피지선내의 피지를 과분비한다(Diane et al; J. Invest Dermatol. 105; 209-214). 5α-Reductase is present in testosterone-reactive tissues such as sebaceous glands, hair follicles, prostate and epididymis, reducing testosterone, one of the testosterones, to Dihydrotestosteron (DHT). As an enzyme involved, its conversion requires nicotinamide adenine dinucleotide phosphate (NADPH). Testosterone is involved in skeletal muscle growth and sperm formation, and dihydrotestosterone is involved in tissues in acne, sebum and prostatic hyperplasia (Diane et al; J. Invest Dermatol. 775-778, 1995. Bruchovsky, N et al; JBC 243, 2112-2121, 1968). In addition, in the sebaceous glands of the skin, testosterone is converted to dihydrotestosterone by 5α-reductase, binds to a receptor protein in the cytoplasm, enters the nucleus, activates sebaceous gland cells, and stimulates differentiation, thereby over secreting sebum in sebaceous glands. (Diane et al; J. Invest Dermatol. 105; 209-214).

이에, 본 발명자들은 상기의 과잉 분비된 피지와 같은 문제를 해결하기 위해 피지의 과분비 자체를 억제할 수 있는 물질을 연구하게 되었고, 이러한 연구의 일환으로 이미 그 안전성이 입증되어 있는 천연물들 중에서 유효물질을 검색한 결과, 산사나무(Hawthorn) 추출물, 담쟁이덩굴(Ivy) 추출물 및 클로브(Clove) 추출물이 5 α-리덕테이즈의 저해효과와 지질 생합성 억제효과가 있으며, 상기 추출물들을 동시에 혼합하여 사용시 그 효과가 훨씬 우수함을 밝혀내어 과잉 분비된 피지를 더욱 효과적으로 억제할 수 있음을 발견하고 본 발명을 완성하게 되었다.Therefore, the present inventors have studied a substance capable of suppressing the excessive secretion of sebum in order to solve the problems such as the excessive secretion of sebum, and as part of this research, an effective substance among natural substances that have already been proven safe. As a result, Hawthorn extract, Ivy extract and Clove extract had inhibitory effect of 5 α-reductase and lipid biosynthesis, and the extracts were mixed and used simultaneously. The present invention was completed by discovering that the effect is much better and thus suppressing excessive secreted sebum more effectively.

따라서, 본 발명의 목적은 상기 언급한 3가지 천연 추출물이 과잉 분비되는 피지를 억제하여 피지관련 질환을 더욱 효과적으로 예방 또는 치료할 수 있는 화장료 조성물을 제공하는 것이다. Accordingly, it is an object of the present invention to provide a cosmetic composition that can more effectively prevent or treat sebum-related diseases by inhibiting sebum that is excessively secreted of the three natural extracts mentioned above.

상기한 목적을 달성하기 위하여, 본 발명은 산사나무(Hawthorn) 추출물, 담쟁이덩굴(Ivy) 추출물 및 클로브(Clove) 추출물을 함유하는 것을 특징으로 하는 피지 억제용 화장료 조성물을 제공한다.In order to achieve the above object, the present invention provides a cosmetic composition for inhibiting sebum containing Hawthorn (Hawthorn) extract, Ivy (Ivy) extract and Clove (Clove) extract.

이하, 본 발명을 보다 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.

산사나무(Hawthorn)는 장미과로 학명은 장미목 장미과 산사나무(Crataegus pinnatifida Bge., C. pinnatifida Bge. var. major N.E.Br. 또는 C.suneata Sieb. et Zucc)이다. 열매의 주성분은 크라테골린산, 시트르산, 타르타르산, 플라본, 당, 글리코사이드, 비타민C 등이다. 산사나무는 소화를 자극하고, 위의 기능적 활동을 촉진하는데 일반적으로 사용된다. 이것은 또한 정상적인 혈액 순환을 개선하고, 울혈을 해소시킬 수 있다. (대한민국 특허공개, 10-2004-0043092)Hawthorn (Hawthorn) is a rosaceae, scientific name is the rosacea rosea (Crataegus pinnatifida Bge., C. pinnatifida Bge.var.major N.E.Br. or C.suneata Sieb. Et Zucc). The main components of the fruit are creagoline acid, citric acid, tartaric acid, flavones, sugars, glycosides, vitamin C and the like. Hawthorn is commonly used to stimulate digestion and promote stomach functional activity. It can also improve normal blood circulation and relieve congestion. (Korean Patent Publication, 10-2004-0043092)

담쟁이덩굴(Ivy)은 쌍떡잎식물 갈매나무목 포도과에 속하는 낙엽활엽 덩굴식물이며 돌담이나 바위 또는 나무줄기에 붙어서 자란다. 줄기는 충분히 성장하면 10m이상 자라며, 잎은 폭이 10-20cm 정도의 달걀 모양으로 잎끝이 뾰족하고 3개로 갈라지며, 밑은 심장 밑 모양이고, 앞면에는 털이 없으며 뒷면 잎맥 위에 잔털이 있고, 가장자리에 불규칙한 톱니가 있고, 잎자루는 잎보다 길다. 꽃은 양성화이고, 6-7월에 황록색으로 피며, 가지 끝 또는 잎겨드랑이에서 나온 꽃대에 많은 수가 달린다. 열매는 흰 가루로 덮이고, 지름이 6-8mm이고, 8-10월에 검게 익는다. 이러한 담쟁이덩굴은 한방에서 어혈을 풀어주고, 관절과 근육의 통증을 완화시켜준다고 알려져 있다. Ivy (Ivy) is a deciduous broad-leaved vine plant belonging to the dicotyledon buckthorn vine family and grows on stone walls, rocks or tree trunks. The stem grows more than 10m when fully grown, and the leaves are 10-20cm wide, egg-shaped, pointed at the tip of the leaf, split into 3, the bottom is heart shaped, hairless on the front, fine hair on the leaf vein on the back, There are irregular sawtooth, petioles longer than leaves. Flowers are bisexual, yellow-green in June-July, with a large number of peduncles from the end of branches or axillary. Fruits are covered with white powder, 6-8mm in diameter, ripen in August-October. These ivy are known to relieve blood in one shot and to relieve pain in joints and muscles.

클로브(Clove)는 학명이 에우게니아 카리오필리에이트(Eugenia caryophyliate)이고, 리날린 아세테이트(Linalyl acetate), 리날룰(Linalool) 및 유지놀(Eugenol)을 주 구성성분으로 하며, 항경련, 항우울 및 강한 신경계 진정효과 등이 있는 것으로 알려져 있다. Clove is the scientific name Eugenia caryophyliate, and its main components are Linalyl acetate, Linalool, and Eugenol. And strong nervous system sedation effects.

상기의 3가지 추출물은 용매추출, 수증기증류 또는 초임계 추출기술을 이용한 이산화탄소에 의한 추출 등의 추출조작법을 사용할 수도 있다.The three extracts may be an extraction operation such as solvent extraction, steam distillation or extraction by carbon dioxide using a supercritical extraction technique.

본 발명자들은 피지분비를 유발한다고 알려진 디하이드로테스토스테론의 양을 조절하고자, 디하이드로테스토스테론의 생성을 촉매하는 효소인 5α-리덕테이즈의 활성을 억제하는 천연 추출물을 찾고자 하였다. 시험관내(in vitro)에서 5α-리덕테이즈의 활성을 저해하는지를 실험한 결과, 산사나무(Hawthorn), 담쟁이덩굴(Ivy) 및 클로브(Clove) 추출물이 5α-리덕테이즈의 억제제 역할을 한다는 것을 발견하였다. To control the amount of dihydrotestosterone known to induce sebum secretion, the present inventors sought to find a natural extract that inhibits the activity of 5α-reductase, an enzyme that catalyzes the production of dihydrotestosterone. Experiments have shown that inhibition of 5α-reductase activity in vitro shows that Hawthorn, Ivy and Clove extracts act as inhibitors of 5α-reductase. Found.

그리고, 상기 3가지의 추출물이 모두 함유되어 있을 때 가장 우수한 효과를 나타냄을 발견하였다 (시험예 1). And, it was found that the best effect when all three extracts are contained (Test Example 1).

또한, 피지분비가 많다고 느끼는 남녀 10명을 선정하여 상기 3가지 추출물이 함유된 화장료 조성물을 얼굴에 도포하였을 때에 얼굴에서의 피지부비가 감소함을 발견할 수 있었다 (시험예 2). In addition, it was found that sebum secretion on the face was reduced when 10 men and women who felt that there was a lot of sebum secretion were applied to the face by applying the cosmetic composition containing the three extracts (Test Example 2).

따라서, 본 발명은 산사나무(Hawthorn), 담쟁이덩굴(Ivy) 및 클로브(Clove)의 추출물을 이용하여 5α-리덕테이즈의 활성 저해 및 피지분비를 더욱 효과적으로 감소시키는데 사용하고자 한다.Therefore, the present invention intends to use the extracts of Hawthorn, Ivy and Clove to more effectively reduce the inhibition and sebum secretion of 5α-reductase.

상기 추출물들은 화장료 조성물 전체 중량에 대하여, 총 0.001~10 중량% 함유되는 것이 바람직하다. 이는 상기 추출물들의 총 함량이 0.001 중량% 미만일 경우에는 피지 억제 효과가 미미하고, 10 중량% 초과일 경우에는 화장품 사용감에 큰 영향을 미치기 때문이다. The extract is preferably contained 0.001 ~ 10% by weight based on the total weight of the cosmetic composition. This is because when the total content of the extract is less than 0.001% by weight, the sebum inhibitory effect is insignificant, and when the total content of the extracts is greater than 10% by weight, it has a great influence on the feeling of cosmetic use.

이하, 실시예 및 시험예를 들어 본 발명을 보다 상세히 설명하지만, 본 발명이 이들 예로만 한정되는 것은 아니다.Hereinafter, although an Example and a test example are given and this invention is demonstrated in detail, this invention is not limited only to these examples.

[제조예 1] 산사나무(Hawthorn) 추출물의 제조Preparation Example 1 Preparation of Hawthorn Extract

건조중량 200g의 산사나무 열매를 50% 1,3-부틸렌 글리콜산(1,3-butylene glycolic acid) 용액을 사용하여 추출한다. 이를 다시 농축하여 2g의 산사나무 추출물을 얻었다. 200g dry weight hawthorn fruit is extracted using 50% 1,3-butylene glycolic acid solution. This was concentrated again to obtain 2 g of hawthorn extract.

[제조예 2] 담쟁이덩굴(Ivy) 추출물의 제조Preparation Example 2 Preparation of Ivy Extract

건조중량 382g의 담쟁이덩굴을 60% 에탄올을 사용하여 추출한다. 이를 다시 농축하여 1.79g의 담쟁이덩굴 추출물을 얻었다. 382 g dry weight ivy is extracted using 60% ethanol. This was concentrated again to obtain 1.79 g of ivy extract.

[제조예 3] 클로브(Clove) 추출물의 제조Preparation Example 3 Preparation of Clove Extract

유리제 용기를 사용하여, 클로브 분말 600g을 5배 용량의 에틸아세테이트에 침지하고, 실온 및 차광상태에서 가끔 교반하면서 1주동안 방치한다. 상기 혼합물을 여과지에 2회 여과하여 분말을 제거하고, 추출액을 얻는다. 그 추출액을 감압 농축하여 용매를 제거하고, 클로브 추출물 48g을 얻었다. Using a glass container, 600 g of clove powder is immersed in a 5-fold volume of ethyl acetate and left for 1 week with occasional stirring at room temperature and in a light-shielded state. The mixture is filtered twice on filter paper to remove powder and to obtain an extract. The extract was concentrated under reduced pressure to remove the solvent, and 48 g of clove extracts were obtained.

[실시예 1] 유연 화장수Example 1 Flexible Lotion

상기 제조예 1~3에서 제조한 산사나무 추출물, 담쟁이덩굴 추출물 및 클로브 추출물을 그 합이 총 3.00 중량% 함유되도록 하여, 하기 표 1과 같은 조성으로 유연화장수를 제조하였다. The sum of the hawthorn extract, ivy extract and clove extract prepared in Preparation Examples 1 to 3 contained a total of 3.00% by weight, thereby preparing flexible cosmetics with the composition shown in Table 1 below.

성 분          ingredient 함 량 (중 량%)Content (% by weight) 산사나무 + 담쟁이덩굴 + 클로브 추출물 Hawthorn + Ivy + Clove Extract 3.003.00 폴리솔베이트 Polysorbate 1.501.50 솔비탄세스퀴올레이트 Sorbitan sesquioleate 1.001.00 에탄올 ethanol 8.008.00 카프릴릭/카프릭트리글리세라이드 Caprylic / Capric Triglycerides 4.004.00 글리세린 glycerin 5.005.00 부틸렌글라이콜 Butylene Glycol 5.005.00 프로필렌글라이콜 Propylene glycol 3.003.00 방부제 antiseptic 적량Quantity 색소 Pigment 적량Quantity 향료 Spices 적량Quantity 정제수 Purified water To 100To 100

[시험예 1] 5α-리덕테이즈 활성 억제효과Test Example 1 Inhibitory Effect of 5α-Reductase Activity

성숙한 Sprogue-Dawley 웅성랫트(생후 7-8주)를 디에틸에테르로 치사시킨 후, 복부 전립선을 떼내어 결합조직을 제거하고, 완충액(0.32M 슈크로오즈(sucrose), 0.1mM 디티오트레이톨(dithiothreitol), 20mM 소디움 아세테이트(sodium acetate))을 첨가하여 잘게 자른 다음, 분쇄기로 현탁화 하였다. 현탁액은 원심분리하여 상층액을 취해 5α-리덕테이즈를 부분정제하여, 이 효소의 활성도 억제실험을 수행하였다. Mature Sprogue-Dawley male rats (7-8 weeks old) were killed with diethyl ether, and then the abdominal prostate was removed to remove connective tissue and buffered (0.32 M sucrose, 0.1 mM dithiothreitol). (dithiothreitol), 20 mM sodium acetate, was added to finely chopped and suspended in a grinder. The suspension was centrifuged to obtain supernatant, partially purified 5α-reductase, and the activity inhibition experiment of this enzyme was performed.

위에서 얻은 상층액의 일부를 취하여 0.2M 일염기산과 0.2M 이염기산이 들어있는 완충액에 넣은 후, 동위원소인 3H가 붙어있는 기질(테스토스테론)과 함께 반응시켜 생성물인 디하이드로테스토스테론의 생성량을 측정하였다. 반응용액은 1mM 디티오트레이톨, 40mM 나트륨 포스페이트(pH 6.5), 50μM NADPH, [1,2,6,7-3H]테스토스테론/테스토스테론 및 효소현탁액(0.8mg)을 넣어 총 부피가 565 μl가 되게 하였다. Taking a portion of the supernatant obtained above was placed in a buffer containing 0.2M monobasic acid and 0.2M dibasic acid, is reacted with isotope substrate (testosterone) marked with 3 H measure the amount of dihydrotestosterone product It was. The reaction solution was added 1 mM dithiothreitol, 40 mM sodium phosphate (pH 6.5), 50 μM NADPH, [1,2,6,7-3H] testosterone / testosterone and enzyme suspension (0.8 mg) to a total volume of 565 μl. It was.

시료는 10% 에탄올에 0.1%가 되도록 녹인 후, 위의 반응용액을 5.65μl 첨가하여 최종농도가 0.001%가 되도록 하였다. 대조군으로는 같은 부피의 용매, 양성대조군으로는 피나스테라이드(Finasteride)를 이용하였다. 피나스테라이드는 5α-리덕테이즈의 저해제로서 잘 알려진 물질로 미국 FDA의 승인을 받은 물질이다. 현재 미국의 머크사에서는 이 물질을 기초로 5α-리덕테이즈 효과에 우수한 프로페시아라는 제품을 제조, 판매하고 있다. The sample was dissolved in 10% ethanol to 0.1%, and then 5.65 μl of the above reaction solution was added so that the final concentration was 0.001%. The same volume of solvent was used as a control group, and finasteride was used as a positive control group. Finasteride is a well known inhibitor of 5α-reductase and is approved by the US FDA. Currently, Merck, USA, manufactures and sells a product called Propecia, which has an excellent 5α-reductase effect.

반응은 효소현탁액을 부가함과 동시에 시작하여 37℃에서 30분간 진행시킨 후, 1ml의 에틸아세테이트를 가하여 추출하였으며, 100μl 의 에틸아세테이트상을 실리카 플라스틱시트 카이젤겔 60F 254 (Silica plastic sheet kieselgel F254)상에서 전개용매계는 아세테이트-사이클로헥산(1:1)으로 하여 전개하였다.The reaction was started at the same time as the addition of the enzyme suspension and proceeded at 37 ° C. for 30 minutes, followed by extraction with 1 ml of ethyl acetate. 100 μl of ethyl acetate was extracted on silica plastic sheet kieselgel F254. The developing solvent system was developed with acetate-cyclohexane (1: 1).

플라스틱 시료를 공기중에서 건조한 후, 동위원소의 양을 측정하기 위해 바스 시스템을 사용하였는데, 건조된 플라스틱 시트와 엑스레이 필름을 함께 바스 카셋트에 넣어 1주일 후에 필름에 남아있는 테스토스테론과 디하이드로테스토스테론의 동위원소양을 측정하였다. After drying the plastic sample in air, a bath system was used to measure the isotope amount. The dried plastic sheet and the x-ray film were put together in a bath cassette, and after one week the copper member of testosterone and dihydrotestosterone remained on the film. The quantification was measured.

각각의 저해율에 대한 결과는 하기 [표 2]에 나타내었다. 한편, 하기 [표 2]의 시료에서 각 제조예들의 혼합비율은 1:1이다. The results for each inhibition rate are shown in Table 2 below. On the other hand, in the samples of the following Table 2, the mixing ratio of each preparation example is 1: 1.

시 료 (0.001%)  Sample (0.001%) T(dpm)T (dpm) DHT(dpm)DHT (dpm) 전환율(%)% Conversion 저해율(%)% Inhibition 제조예 1 Preparation Example 1 76807680 21052105 25.325.3 47.347.3 제조예 2 Preparation Example 2 84508450 27502750 26.326.3 45.245.2 제조예 3 Preparation Example 3 75407540 23002300 24.824.8 48.348.3 제조예 1 + 제조예 2 Preparation Example 1 + Preparation Example 2 69806980 18901890 23.123.1 51.951.9 제조예 1 + 제조예 3 Preparation Example 1 + Preparation Example 3 81308130 20102010 21.221.2 55.855.8 제조예 2 + 제조예 3 Preparation Example 2 + Preparation Example 3 68356835 18401840 19.119.1 60.260.2 제조예 1 + 제조예 2 + 제조예 3 Preparation Example 1 + Preparation Example 2 + Preparation Example 3 91059105 29902990 17.117.1 64.464.4 대조군 Control 74307430 59355935 48.048.0 -- 양성대조군 Positive control group 75007500 25302530 29.929.9 37.737.7

(1) T: 테스토스테론 영역에서 나타난 3H 방사능(Radio activity)(1) T: 3H Radio activity in the testosterone region

(2) DHT: 디하이드로테스토스테론 영역에서 나타난 3H 방사능(Radio activity)(2) DHT: 3H radioactivity in the dihydrotestosterone region

(3) 전환율: DHT영역에의 방사능(radio activity) / 총 방사능(Total Radio Activity)(3) Conversion rate: radioactivity to the DHT region / total radio activity

(4) 저해율: 100*(대조군의 전환율-시료의 전환율) / 대조군의 전환율(4) Inhibition rate: 100 * (control conversion-sample conversion) / control conversion

상기 [표 2]의 결과로부터, 산사나무(Hawthorn) 추출물, 담쟁이덩굴(Ivy) 추출물 및 클로브(Clove) 추출물을 모두 혼합할 경우, 상기 추출물을 개별적으로 함유하는 때보다 5α-리덕테이즈 저해효과가 훨씬 뛰어남을 확인할 수 있었다.From the results of the above [Table 2], when mixing all Hawthorn extract, Ivy extract and Clove extract, 5α-reductase inhibitory effect than when containing the extract individually Could see much better.

[시험예 2] 피지분비 억제효과Test Example 2 Sebum Secretion Inhibitory Effect

피지분비가 많다고 느끼는 피험자 남녀 10명을 선정하여 실시예 1의 [표 1]에 따른 처방으로 4주간 얼굴의 피지가 많은 곳을 매일 바르게 한 결과 다음 [표 3]과 같은 결과를 얻었다.Ten subjects men and women who felt that there was a lot of sebum secretion were selected, and according to the prescription according to [Table 1] of Example 1, a lot of sebum of the face was corrected every day for four weeks.

피 험 자   Subject 시험전피지량 (μg/cm2h)Pre-test amount (μg / cm 2 h) 시험 2주경과 후    After 2 weeks of exam 시험 4주경과 후     After 4 weeks of exam 1One 7676 6565 6262 22 6969 6464 5353 33 9494 8585 7979 44 101101 9494 8787 55 8686 8080 7575 66 7575 6969 6161 77 6969 6565 5858 88 7474 6666 6060 99 6565 5656 5050 1010 5959 5151 4545

상기 [표 3]의 결과로부터, 본 발명에 따른 화장료 조성물은 피지를 효과적으로 억제할 수 있음을 알 수 있었다.From the results in Table 3, it can be seen that the cosmetic composition according to the present invention can effectively inhibit sebum.

이상에서 상술한 바와 같이, 산사나무(Hawthorn) 추출물, 담쟁이덩굴(Ivy) 추출물 및 클로브(Clove) 추출물을 동시에 함유한 피지분비 억제용 화장료 조성물은 인체에 도포시 매우 안전하면서도 피지분비를 감소시키는 효과가 우수하므로, 지루성 피부염, 여드름에 의한 모공확대와 같은 피지 관련 질환의 예방 또는 치료제에 유용하게 사용될 수 있다.As described above, sebum secretion cosmetic composition containing Hawthorn extract, ivy (Ivy) extract and Clove extract at the same time is very safe when applied to the human body while reducing the sebum secretion effect Since it is excellent, it can be usefully used for the prevention or treatment of sebum-related diseases such as seborrheic dermatitis, enlargement of pores by acne.

Claims (4)

산사나무(Hawthorn) 추출물, 담쟁이덩굴(Ivy) 추출물 및 클로브(Clove) 추출물을 함유하는 것을 특징으로 하는 피지분비 억제용 화장료 조성물.A cosmetic composition for inhibiting sebum secretion, comprising hawthorn extract, ivy extract, and clove extract. 산사나무(Hawthorn) 추출물, 담쟁이덩굴(Ivy) 추출물 및 클로브(Clove) 추출물을 함유하는 것을 특징으로 하는 5α-리덕테이즈 활성 저해용 화장료 조성물.A cosmetic composition for inhibiting 5α-reductase activity, comprising hawthorn extract, ivy extract, and clove extract. 제 1항 또는 제 2항에 있어서, 상기 화장료 조성물은 조성물 전체 중량에 대하여 산사나무(Hawthorn) 추출물, 담쟁이덩굴(Ivy) 추출물 및 클로브(Clove) 추출물을 총 0.001-10 중량%로 함유함을 특징으로 하는 화장료 조성물.The cosmetic composition of claim 1 or 2, wherein the cosmetic composition contains a total of 0.001-10% by weight of Hawthorn extract, Ivy extract and Clove extract based on the total weight of the composition. Cosmetic composition to be. 제 1항 또는 제 2항에 있어서, 상기 화장료 조성물은 유연화장수, 영양화장수, 마사지 크림, 영양크림, 팩, 젤, 에센스, 립스틱, 메이컵 베이스, 파운데이션, 로션, 연고, 겔, 크림, 패취 또는 분무제로 제형화 됨을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1 or 2, wherein the cosmetic composition is a softening cream, a nutrient cream, a massage cream, a nourishing cream, a pack, a gel, an essence, a lipstick, a makeup base, a foundation, a lotion, an ointment, a gel, a cream, a patch or Cosmetic composition, characterized in that formulated as a spray.
KR1020060021063A 2006-03-06 2006-03-06 Cosmetic composition for protecting sebum secretion on the skin KR101252550B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060021063A KR101252550B1 (en) 2006-03-06 2006-03-06 Cosmetic composition for protecting sebum secretion on the skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060021063A KR101252550B1 (en) 2006-03-06 2006-03-06 Cosmetic composition for protecting sebum secretion on the skin

Publications (2)

Publication Number Publication Date
KR20070091482A true KR20070091482A (en) 2007-09-11
KR101252550B1 KR101252550B1 (en) 2013-04-08

Family

ID=38689267

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060021063A KR101252550B1 (en) 2006-03-06 2006-03-06 Cosmetic composition for protecting sebum secretion on the skin

Country Status (1)

Country Link
KR (1) KR101252550B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101407659B1 (en) * 2012-01-31 2014-06-13 한림대학교 산학협력단 A composition for inhibiting testosterone 5-alpha reductase
KR20200017156A (en) * 2018-08-08 2020-02-18 애경산업(주) The composition comprising extract of Rhamnus davurica for improving acne

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102163806B1 (en) 2018-07-30 2020-10-07 주식회사 엑소코바이오 Composition for reducing sebum release comprising an exosome derived from stem cell as an active ingredient
KR102022400B1 (en) * 2019-04-30 2019-09-18 (주)진셀팜 A cosmetic compositon for anti-pollution containing natural complex extract

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164712A (en) 1983-03-09 1984-09-17 Kanebo Ltd Skin makeup composition having improved inhibitory action on sebum secretion
JPH02218604A (en) * 1989-02-21 1990-08-31 Kanebo Ltd Hair-tonic cosmetic
JP2001064122A (en) 1999-08-23 2001-03-13 Pola Chem Ind Inc Sheet-formed preparation for external use for skin
JP2004107244A (en) 2002-09-17 2004-04-08 Fancl Corp Sebum secretion control kit

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101407659B1 (en) * 2012-01-31 2014-06-13 한림대학교 산학협력단 A composition for inhibiting testosterone 5-alpha reductase
KR20200017156A (en) * 2018-08-08 2020-02-18 애경산업(주) The composition comprising extract of Rhamnus davurica for improving acne

Also Published As

Publication number Publication date
KR101252550B1 (en) 2013-04-08

Similar Documents

Publication Publication Date Title
JP3529811B2 (en) External preparation for skin
KR100443588B1 (en) Cosmetic composition containing paeonia suffruticosa andrews extract and albizzia julibrissin dura extract having anti-ageing effect
KR101252550B1 (en) Cosmetic composition for protecting sebum secretion on the skin
KR101654308B1 (en) Composition for improving hair having effect of depilation prevention and good hair
KR100754748B1 (en) Compositiion for Inhibiting 5?-Reductase Activity and Cosmetic Composition for Inhibiting Secretion of Sebum containing Extract of Ulmus davidiana as Active Ingredient
KR101639578B1 (en) Cosmetic composition containing Ocimum basilicum seed extract
KR100482694B1 (en) Liposome base for trichogenousness, Cosmetic composition for trichogenousness containing the same, and Method for improving absorptance of natural ingredients for trichogenousness using the same
KR100858627B1 (en) Cosmetic Composition for Inhibiting Secretion of Sebum containing Extract of Fritillaria verticillata as Active Ingredient
KR20090032583A (en) ALPINIA OFFICINARUM EXTRACT FOR INHIBITING OF 5alpha;-REDUCTASE ACTIVITY AND COSMETIC COMPOSITION FOR INHIBITING OF SEBUM SECRETION OR IMPROVING OF ACNES
KR102441009B1 (en) Methods for extracting compound from ginseng, ginseng extract comprising the compound and composition for enhancing skin barrier comprising the same
KR20130066466A (en) Cosmetic composition comprising the mixed extracts of achillea, borage, helichrysum, lady's mantle, and eucalyptus
KR20130115497A (en) Cosmetic composition containing fermented extracts of panax ginseng root, ganoderma lucidum and white tea and method for preparing the same
KR100702329B1 (en) Compositiion for Inhibiting 5?-Reductase Activity and Cosmetic Composition for Inhibiting Secretion of Sebum containing Extract of Chelidonium majus as Active Ingredient
JP2004352658A (en) External preparation for skin
KR101969684B1 (en) A cosmetic composition for anti-wrinkle and skin pore reduction containing natural spicule powder and natural complex extract
KR100927970B1 (en) Sebum secretion containing acryl extract as an active ingredient and acne relief cosmetic composition
KR100310613B1 (en) Euphorbia Lathyris extract inhibiting the activity of 5a-reductase, and the cosmetic or skincare-pharmaceutical composition thereof for suppressing pimple or sebum
KR102093708B1 (en) A cosmetic composition using Fraxini cortex extract
KR20210059517A (en) Quadruple complex and the composition ratio using Moringa Oleifera Oil, Vitellaria Nilotica (Shea) Butter, Centella Asiatica Extract, Glycyrrhiza Uralensis Extract for maximizing atopic dermatitis improvement and preventive efficacy
KR20020008268A (en) Testosterone 5 alpha-reductase inhibitors containing extracts of galla rhois
KR20200139368A (en) Solid fermentation composition manufactured by rumex coreanus and vegetable worms and functional cosmetic composition comprising the same
KR101762575B1 (en) Whitening cosmetic composition comprising withanolide of Withania somnifera
TWI816128B (en) Use of extract of angelica dahurica var. formosana
KR102504878B1 (en) cosmetic composition having anti-inflammatory and skin soothing and effects and improvement of skin itching containing fermented extracts of Campsis grandiflora, Plum blossom, Quercus acuta THUNB
KR20120001161A (en) Composition for moisturizing skin containing extracts prepared by enzyme process

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20170329

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20180329

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20190325

Year of fee payment: 7